Mersana Therapeutics, Inc.
NASDAQ:MRSN
1.5 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 12.598 | 2.293 | 9.245 | 10.701 | 7.698 | 10.654 | 7.802 | 14.688 | 5.573 | 4.284 | 2.036 | 0.011 | 0.011 | 0.011 | 0.011 | 0.011 | 0.011 | 0.796 | 0.011 | 0.042 | 0.844 | 0.202 | 41.035 | 1.188 | 2.151 | 4.191 | 3.064 | 3.261 | 6.267 | 3.727 | 4.29 | 11.996 | 3.262 | 6.215 | 3.697 |
| Cost of Revenue
| 0 | 17.245 | 0.423 | 0.447 | 0.427 | 0.324 | 0.319 | 0.282 | 50.639 | 41.231 | 0.205 | 37.368 | 35.275 | 31.955 | 27.415 | 22.857 | 16.546 | 15.413 | 12.219 | 12.43 | 13.701 | 13.766 | 15.143 | 19.817 | 15.18 | 12.663 | 12.256 | 14.555 | 11.412 | 10.627 | 10.106 | 8.845 | 7.555 | 8.171 | 7.436 |
| Gross Profit
| 12.598 | -14.952 | 8.822 | 10.254 | 7.271 | 10.33 | 7.483 | 14.406 | -45.066 | -36.947 | 1.831 | -37.357 | -35.264 | -31.944 | -27.404 | -22.846 | -16.535 | -14.617 | -12.208 | -12.388 | -12.857 | -13.564 | 25.892 | -18.629 | -13.029 | -8.472 | -9.192 | -11.294 | -5.145 | -6.9 | -5.816 | 3.151 | -4.293 | -1.956 | -3.739 |
| Gross Profit Ratio
| 1 | -6.521 | 0.954 | 0.958 | 0.945 | 0.97 | 0.959 | 0.981 | -8.086 | -8.624 | 0.899 | -3,396.091 | -3,205.818 | -2,904 | -2,491.273 | -2,076.909 | -1,503.182 | -18.363 | -1,109.818 | -294.952 | -15.233 | -67.149 | 0.631 | -15.681 | -6.057 | -2.021 | -3 | -3.463 | -0.821 | -1.851 | -1.356 | 0.263 | -1.316 | -0.315 | -1.011 |
| Reseach & Development Expenses
| 14.803 | 17.245 | 18.686 | 21.495 | 30.531 | 48.968 | 47.275 | 45.709 | 50.639 | 41.231 | 35.806 | 37.368 | 35.275 | 31.955 | 27.415 | 22.857 | 16.546 | 15.413 | 12.219 | 12.43 | 13.701 | 13.766 | 15.143 | 19.816 | 15.18 | 12.663 | 12.256 | 14.555 | 11.412 | 10.627 | 10.106 | 8.845 | 7.555 | 8.171 | 7.436 |
| General & Administrative Expenses
| 9.864 | 10.503 | 11.56 | 10.134 | 12.894 | 18.187 | 18.328 | 14.805 | 14.573 | 14.803 | 12.782 | 10.674 | 10.124 | 8.883 | 7.208 | 5.914 | 5.881 | 5.171 | 4.936 | 4.212 | 4.436 | 4.192 | 4.443 | 4.152 | 4.38 | 4.231 | 3.571 | 3.056 | 2.905 | 2.204 | 2.296 | 1.94 | 1.598 | 1.826 | 1.621 |
| Selling & Marketing Expenses
| 0 | 0 | -0.423 | -0.447 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 9.864 | 10.503 | 11.137 | 9.687 | 12.894 | 18.187 | 18.328 | 14.805 | 14.573 | 14.803 | 12.782 | 10.674 | 10.124 | 8.883 | 7.208 | 5.914 | 5.881 | 5.171 | 4.936 | 4.212 | 4.436 | 4.192 | 4.443 | 4.152 | 4.38 | 4.231 | 3.571 | 3.056 | 2.905 | 2.204 | 2.296 | 1.94 | 1.598 | 1.826 | 1.621 |
| Other Expenses
| -12.069 | 0 | 0 | -1.695 | 8.214 | 2.194 | 0 | 0.902 | -0.172 | 0 | 0 | -0.952 | 0 | -0.086 | 0 | 0 | -0.073 | 0 | 0 | 0 | 0 | 0 | 0.452 | 0.349 | 0 | 0 | 0.36 | 0 | 0.318 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 12.598 | 27.748 | 29.823 | 31.182 | 51.639 | 67.155 | 65.603 | 60.514 | 65.212 | 56.034 | 48.588 | 48.042 | 45.399 | 40.838 | 34.623 | 28.771 | 22.427 | 20.584 | 17.155 | 16.642 | 18.137 | 17.958 | 19.586 | 23.968 | 19.56 | 16.894 | 15.827 | 17.611 | 14.317 | 12.831 | 12.402 | 10.785 | 9.153 | 9.997 | 9.057 |
| Operating Income
| -12.069 | -25.455 | -21.001 | -20.928 | -41.656 | -54.307 | -55.18 | -46.108 | -59.639 | -51.75 | -46.534 | -48.002 | -45.388 | -40.827 | -34.612 | -28.76 | -22.416 | -19.788 | -17.144 | -16.599 | -17.293 | -17.756 | 21.449 | -22.781 | -17.409 | -12.703 | -12.763 | -14.35 | -8.05 | -9.104 | -8.112 | 1.211 | -5.891 | -3.782 | -5.36 |
| Operating Income Ratio
| -0.958 | -11.101 | -2.272 | -1.956 | -5.411 | -5.097 | -7.073 | -3.139 | -10.701 | -12.08 | -22.856 | -4,363.818 | -4,126.182 | -3,711.545 | -3,146.545 | -2,614.545 | -2,037.818 | -24.859 | -1,558.545 | -395.214 | -20.489 | -87.901 | 0.523 | -19.176 | -8.093 | -3.031 | -4.165 | -4.4 | -1.285 | -2.443 | -1.891 | 0.101 | -1.806 | -0.609 | -1.45 |
| Total Other Income Expenses Net
| 0.986 | 1.187 | 1.695 | 1.384 | -5.929 | 2.194 | 1.638 | 0.902 | -0.172 | -0.469 | -0.706 | -0.952 | -0.083 | -0.086 | -0.081 | -0.08 | -0.073 | 0.002 | 0.218 | 0.353 | 0.501 | 0.685 | 0.452 | 0.349 | 0.34 | 0.349 | 0.36 | 0.383 | 0.318 | 0.158 | 0.051 | 0.048 | 0.054 | 0.016 | 0.004 |
| Income Before Tax
| -11.083 | -24.268 | -19.306 | -19.544 | -41.656 | -54.307 | -56.163 | -44.924 | -59.811 | -52.219 | -47.258 | -48.983 | -45.471 | -40.913 | -34.693 | -28.842 | -22.489 | -19.786 | -16.926 | -16.246 | -16.792 | -17.071 | 21.901 | -22.431 | -17.069 | -12.354 | -12.403 | -13.967 | -7.732 | -8.946 | -8.061 | 1.259 | -5.837 | -3.766 | -5.356 |
| Income Before Tax Ratio
| -0.88 | -10.584 | -2.088 | -1.826 | -5.411 | -5.097 | -7.199 | -3.059 | -10.732 | -12.189 | -23.211 | -4,453 | -4,133.727 | -3,719.364 | -3,153.909 | -2,622 | -2,044.455 | -24.857 | -1,538.727 | -386.81 | -19.896 | -84.51 | 0.534 | -18.881 | -7.935 | -2.948 | -4.048 | -4.283 | -1.234 | -2.4 | -1.879 | 0.105 | -1.789 | -0.606 | -1.449 |
| Income Tax Expense
| 0.418 | 0 | 0.38 | 5.697 | -6.356 | -0.324 | 0.983 | 0.964 | -0.213 | 0.291 | 0.724 | 0.981 | 0.015 | -0.206 | 0.012 | 0.01 | -0.256 | 0.089 | 0.306 | 0.158 | 0.608 | 0.725 | -0.337 | -0.35 | 0 | 0 | -0.258 | 0 | -0.235 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -11.501 | -24.268 | -19.306 | -19.544 | -41.656 | -54.307 | -57.146 | -45.888 | -59.811 | -52.219 | -47.982 | -48.983 | -45.471 | -40.913 | -34.693 | -28.842 | -22.489 | -19.786 | -16.926 | -16.246 | -16.792 | -17.071 | 21.901 | -22.431 | -17.069 | -12.354 | -12.403 | -13.967 | -7.732 | -8.946 | -8.061 | 1.259 | -5.837 | -3.766 | -5.356 |
| Net Income Ratio
| -0.913 | -10.584 | -2.088 | -1.826 | -5.411 | -5.097 | -7.325 | -3.124 | -10.732 | -12.189 | -23.567 | -4,453 | -4,133.727 | -3,719.364 | -3,153.909 | -2,622 | -2,044.455 | -24.857 | -1,538.727 | -386.81 | -19.896 | -84.51 | 0.534 | -18.881 | -7.935 | -2.948 | -4.048 | -4.283 | -1.234 | -2.4 | -1.879 | 0.105 | -1.789 | -0.606 | -1.449 |
| EPS
| -0.094 | -0.2 | -0.16 | -0.16 | -0.35 | -0.47 | -0.53 | -0.45 | -0.61 | -0.55 | -0.6 | -0.68 | -0.63 | -0.59 | -0.5 | -0.42 | -0.33 | -0.33 | -0.35 | -0.34 | -0.35 | -0.36 | 0.72 | -0.97 | -0.74 | -0.54 | -0.54 | -0.61 | -0.35 | -6.33 | -0.36 | 0.072 | -0.33 | -0.22 | -0.31 |
| EPS Diluted
| -0.094 | -0.2 | -0.16 | -0.16 | -0.35 | -0.47 | -0.53 | -0.45 | -0.61 | -0.55 | -0.6 | -0.68 | -0.63 | -0.59 | -0.5 | -0.42 | -0.33 | -0.33 | -0.35 | -0.34 | -0.35 | -0.36 | 0.7 | -0.97 | -0.74 | -0.54 | -0.54 | -0.61 | -0.35 | -6.33 | -0.36 | 0.072 | -0.33 | -0.22 | -0.31 |
| EBITDA
| -11.667 | -22.882 | -17.881 | -18.049 | -40.212 | -52.958 | -54.861 | -43.678 | -58.718 | -51.232 | -46.329 | -47.791 | -45.161 | -40.612 | -34.374 | -28.492 | -22.141 | -19.453 | -16.59 | -15.877 | -16.375 | -16.715 | 21.786 | -22.431 | -16.727 | -12.047 | -12.505 | -14.095 | -7.815 | -8.875 | -7.903 | 1.417 | -5.707 | -3.632 | -5.245 |
| EBITDA Ratio
| -0.926 | -9.979 | -2.226 | -1.914 | -5.411 | -5.303 | -7.032 | -3.12 | -10.701 | -11.959 | -22.755 | -4,366.455 | -4,105.545 | -3,711.545 | -3,124.909 | -2,590 | -2,037.818 | -24.438 | -1,508.182 | -384.738 | -19.402 | -82.748 | 0.523 | -19.175 | -7.934 | -2.958 | -4.165 | -4.322 | -1.285 | -2.381 | -1.842 | 0.118 | -1.75 | -0.584 | -1.419 |